Measurement of Blood-Brain Barrier Hyperpermeability Using Evans Blue Extravasation Assay.

Area of Science:

• Neuroscience
• Pathology
• Biomedical Engineering

Background:

• Blood-brain barrier (BBB) dysfunction is a hallmark of numerous brain pathologies, including traumatic brain injury and ischemic events.
• The BBB normally restricts the passage of large molecules like albumin into the brain parenchyma.
• Hyperpermeability of the BBB allows albumin and other substances to leak into the brain, contributing to pathology.

Purpose of the Study:

• To describe a standardized procedure for evaluating BBB integrity and hyperpermeability using the Evans Blue assay.
• To demonstrate the application of this assay in a mouse model of traumatic brain injury.
• To establish Evans Blue extravasation as a quantifiable indicator of BBB dysfunction.

Main Methods:

• Intravenous injection of Evans Blue dye into mice.
• Extraction of Evans Blue dye from brain tissue following injury.
• Measurement of Evans Blue fluorescence intensity to quantify dye extravasation.

Main Results:

• Evans Blue extravasation was observed in the mouse model of traumatic brain injury, indicating BBB hyperpermeability.
• The fluorescence intensity of extracted Evans Blue directly correlated with the degree of BBB dysfunction.
• The described method provides a reliable and quantifiable assessment of BBB integrity.

Conclusions:

• The Evans Blue assay is a valuable tool for assessing BBB hyperpermeability in preclinical models of brain disorders.
• Quantification of Evans Blue extravasation offers a direct measure of BBB dysfunction.
• This method aids in understanding the role of BBB breakdown in neurological diseases and evaluating potential therapeutic interventions.